GCL
PSTX

Glazer Capital LLC’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Glazer Capital LLC’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-521,113
Closed -$5M – 226
2024
Q4 		$5M Buy
+521,113
New +$5M 0.34% 45